Oklahoma State Courts Network
Administration of Medicine
Administration of Emergency Opioid Antagonist - Procedure for Overdose - Authorization of Administration Personnel - Good Samaritan Act
Narcan/anaphylaxis administration; effective July 1, 2023. Allows a school nurse or any person designated by the school administration to administer an opiate antagonist without a prescription in the event of a suspected overdose.
Defines “medical personnel at schools” to mean a certified school nurse or any other nurse employed by or under contract with a school, any licensed practitioner of the healing arts, or any person designated by the school administration to administer an opiate antagonist in the event of a suspected overdose.
Defines “first responder” to include medical personnel at schools including any public or charter schools, technology center schools and institutions of higher education.
Authorizes first responders to administer, without prescription, opiate antagonists when encountering an individual exhibiting signs of an opiate overdose and to provide opiate antagonist to individuals who have experienced or witnessed an opiate overdose for use at a later date.
Authorizes any school nurse, public health nurse, licensed practitioner of the healing arts, nurse working under contract with a school district or any person designated by the school administration to administer an opiate antagonist in the event of a suspected overdose.
Allows the administration of a public school to authorize one or more persons employed by the school to receive training offered by the Department of Mental Health and Substance Abuse Services, a law enforcement agency or any other entity in recognizing the signs of an opiate overdose and administering an opiate antagonist.
Designates persons to receive training including but not limited to the staff members required to receive annual training in cardiopulmonary resuscitation in and the Heimlich maneuver.
Allows opiate antagonist training materials to be accessed online through the State Department of Health or any entity if in-person training is not readily available in the area of the designated person or persons.
Requires the training to include information on how to spot symptoms of an overdose, instruction in basic resuscitation techniques, instruction on proper administration of an opiate antagonist and the importance of calling 911.
Allows the administration of a school to authorize any person to administer an opiate antagonist to a student or other individual exhibiting signs of an overdose in the absence of the person or persons specifically designated and trained to do so.
Allows any person administering an opiate antagonist to a student or other individual at a school site or school-sponsored event in a manner consistent with addressing an opiate overdose to be covered under the Good Samaritan Act. Provides immunity to a school and any of its employees or designee from civil liability in relation to the administration of an opiate antagonist in the event of a suspected overdose.
Oklahoma Legislation
OK SB48
Treatment of cystic fibrosis in schools; effective July 1, 2019. Allows students to self-administer replacement pancreatic enzymes to treat cystic fibrosis. Existing law requires districts to adopt policies permitting the self-administration of certain medications by students with the authorization of a parent or legal guardian.
- Requires school boards to adopt a policy to allow for the self-administration of replacement pancreatic enzymes by a student to treat cystic fibrosis.
- Defines "medication" to include replacement pancreatic enzymes prescribed by a physician and having an individual label for purposes of self-administration.
- Authorizes permission for self-administration of replacement pancreatic enzyme medication to be effective for the school year for which it is granted and requires permission to be renewed each school year.
- Allows a student who is permitted to self-administer a replacement pancreatic enzyme medication to possess and use the medication at all times.